Literature DB >> 34635797

Donor-specific HLA antibodies associate with chronic graft-versus-host disease in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.

Ketevan Gendzekhadze1, Monzr M Al Malki2,3, Michael Carter1, Michiko Taniguchi1, Dongyun Yang4, Shukaib Arslan5, Geoffrey Shouse5, Haris Ali5, Nicole Karras6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34635797      PMCID： PMC8860343          DOI： 10.1038/s41409-021-01494-5

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.174


× No keyword cloud information.
  12 in total

1.  Non-donor specific anti-human leukocyte antigen (HLA) antibodies are not associated with poor outcome in hematopoietic stem cell transplant recipients.

Authors:  J R Andolina; R Walia; J Oliva; A Baran; J Liesveld; M W Becker; A Busacco; M Coppage
Journal:  Hum Immunol       Date:  2020-05-26       Impact factor: 2.850

Review 2.  The role of anti-HLA antibodies in hematopoietic stem cell transplantation.

Authors:  Daniele Focosi; Alessandra Zucca; Fabrizio Scatena
Journal:  Biol Blood Marrow Transplant       Date:  2011-06-16       Impact factor: 5.742

3.  Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes.

Authors:  Stefania Bramanti; Valeria Calafiore; Elena Longhi; Jacopo Mariotti; Loretta Crespiatico; Barbara Sarina; Chiara De Philippis; Angela Nocco; Armando Santoro; Luca Castagna
Journal:  Biol Blood Marrow Transplant       Date:  2019-03-01       Impact factor: 5.742

4.  Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.

Authors:  Stefan O Ciurea; Peter F Thall; Denái R Milton; Titus H Barnes; Piyanuch Kongtim; Yudith Carmazzi; Asdrúbal A López; Dianne Y Yap; Uday Popat; Gabriela Rondon; Benjamin Lichtiger; Fleur Aung; Vahid Afshar-Kharghan; Qing Ma; Marcelo Fernández-Viña; Richard E Champlin; Kai Cao
Journal:  Biol Blood Marrow Transplant       Date:  2015-05-15       Impact factor: 5.742

5.  High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.

Authors:  Stefan O Ciurea; Marcos de Lima; Pedro Cano; Martin Korbling; Sergio Giralt; Elizabeth J Shpall; Xuemei Wang; Peter F Thall; Richard E Champlin; Marcelo Fernandez-Vina
Journal:  Transplantation       Date:  2009-10-27       Impact factor: 4.939

Review 6.  The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.

Authors:  Stefan O Ciurea; Kai Cao; Marcelo Fernandez-Vina; Piyanuch Kongtim; Monzr Al Malki; Ephraim Fuchs; Leo Luznik; Xiao-Jun Huang; Fabio Ciceri; Franco Locatelli; Franco Aversa; Luca Castagna; Andrea Bacigalupo; Massimo Martelli; Didier Blaise; Rupert Handgretinger; Denis-Claude Roy; Paul O'Donnell; Asad Bashey; Hillard M Lazarus; Karen Ballen; Bipin N Savani; Mohamad Mohty; Arnon Nagler
Journal:  Bone Marrow Transplant       Date:  2018-01-15       Impact factor: 5.483

7.  Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols.

Authors:  Robert S Liwski; Anna L Greenshields; David M Conrad; Cathi Murphey; Robert A Bray; Jorge Neumann; Howard M Gebel
Journal:  Hum Immunol       Date:  2017-11-09       Impact factor: 2.850

8.  HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway.

Authors:  Peter T Jindra; Yi-Ping Jin; Enquire Rozengurt; Elaine F Reed
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

9.  Allogeneic dendritic cells stimulated with antibodies against HLA class II polarize naive T cells in a follicular helper phenotype.

Authors:  Olivier Désy; Stéphanie Béland; Patrice Vallin; Julie Riopel; Eva Latulippe; Eric Wagner; Sacha A De Serres
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

10.  Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets.

Authors:  Ying-Jun Chang; Xiang-Yu Zhao; Lan-Ping Xu; Xiao-Hui Zhang; Yu Wang; Wei Han; Huan Chen; Feng-Rong Wang; Xiao-Dong Mo; Yuan-Yuan Zhang; Ming-Rui Huo; Xiao-Su Zhao; Kong Y; Kai-Yan Liu; Xiao-Jun Huang
Journal:  J Hematol Oncol       Date:  2015-07-10       Impact factor: 17.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.